Amgen and Abgenix begin phase III colon combo trial
The clinical trial, called PACCE, is a randomized, multi-center, open-label study, with endpoints of progression-free survival, overall survival and response rate. Enrollment of approximately 1,000 patients is already
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.